Altered cellular energetics is one of the hallmarks of cancer 1,2 and intratumoural lipid metabolism tends to be markedly changed in hepatocellular carcinoma (HCC) 1,[3][4][5] where it manifests as altered intracellular levels triacylglycerol (TAG), phospholipids, cholesterol and ceramide. 3,[6][7][8][9][10][11][12][13][14][15][16][17][18][19] HCC is one of the world's most common cancers 20,21 and can develop from chronic liver diseases that feature dysregulated lipid metabolism, inflammation and hepatocellular death. This pathological sequence is illustrated well in the case of non-alcoholic fatty liver disease (NAFLD) which can lead to nonalcoholic steatohepatitis (NASH) 21,22 and ultimately NASH-HCC. 23 Rewired lipid metabolism in HCC can also be characteristic of different oncogene driver mutations. For example, hepatomas with a CNNTB1 mutation encoding β-catenin are generally 'addicted' to mitochondrial fatty acid β-oxidation (FAO) 24 and have low levels of